Coronavirus Symptoms: Common Signs and When to Seek Care

Fever, cough, and fatigue are the hallmarks of a COVID-19 infection, but the full range of coronavirus symptoms extends well beyond the respiratory tract and has shifted as new variants emerged. A large meta-analysis pooling data from multiple studies found fever in about 81% of confirmed cases, cough in roughly 59%, and fatigue in close to 39%, with shortness of breath and mucus production each affecting about a quarter of patients.¹ Those numbers came from earlier waves of the pandemic, though, and the symptom picture has evolved considerably since then. Understanding which signs to watch for, how they differ from other respiratory infections, and when they cross the line into a medical emergency remains relevant for anyone navigating a positive test or an illness that feels like it could be COVID.

The Core Symptoms Most People Experience

The classic triad of COVID-19 is fever, cough, and difficulty breathing.² In practice, though, the way these symptoms feel varies enormously from person to person. Some people spike high fevers that last for days; others run a low-grade temperature they barely notice. Cough can be dry and persistent or productive with phlegm. Fatigue is one of the most consistent complaints and often the symptom people find most debilitating, sometimes lingering well after the cough and fever have resolved. Muscle aches, headaches, and a sore throat round out the list of symptoms that most patients report during the first week of illness.

One thing that has changed over the pandemic is how common each symptom is. The original and early Alpha variants tended to produce more lower-respiratory involvement, including noticeable shortness of breath. By the time Omicron became dominant, sore throat had become one of the most frequently reported symptoms, showing up in about 71% of Omicron infections compared to around 61% during the Delta wave.³ Many people infected with recent variants describe their illness as feeling more like a bad cold than the severe respiratory disease that characterized the pandemic’s earliest months.

Smell and Taste Loss

The sudden disappearance of smell or taste became one of COVID-19’s signature calling cards early in the pandemic. These sensory disruptions tend to appear early in the course of illness and are more common with SARS-CoV-2 than with other respiratory viruses.⁴ The virus damages supporting cells in the nasal lining rather than the nerve cells themselves, which is why most people eventually recover their senses, though recovery can take weeks or even months.

Not everyone loses smell and taste equally. A study of over 2,200 patients who tested positive found that about 30% reported the symptom, with younger people and women more likely to be affected.⁵ Variant matters too: loss of smell dropped dramatically with Omicron, affecting about 17% of cases compared to roughly 53% during the Delta wave.³ If you suddenly cannot smell your morning coffee or taste your food and have no obvious nasal congestion to explain it, COVID remains high on the list of likely causes, though the symptom is less reliable as a tipoff than it was a few years ago.

Gut Symptoms and Skin Changes

COVID-19 is not exclusively a lung disease. Digestive symptoms show up in a meaningful minority of patients because the virus can enter cells lining the small intestine. Diarrhea has been reported in roughly 8% to 13% of cases, and the virus’s ability to infect gut tissue helps explain why it sometimes appears in stool samples.⁶ Nausea, vomiting, and abdominal pain are less common but well documented. For some patients, gut symptoms show up before the cough or fever does, which can be confusing if you are not expecting a respiratory virus to upset your stomach.

Skin manifestations are rarer but have received attention throughout the pandemic. The most widely discussed is “COVID toes,” a pattern of chilblain-like lesions, typically reddish-purple bumps on the toes or fingers.⁷ Other skin changes that have been linked to the infection include hives, rash patterns that look like measles, and purplish discoloration of the skin. The mechanisms differ depending on the type of skin involvement; some rashes are tied to blood vessel damage associated with moderate-to-severe disease, while COVID toes appear to result from an exaggerated immune response in people whose bodies are actually fighting off the virus effectively.⁸

Incubation Period and How Symptoms Unfold

After exposure to the virus, you typically will not feel anything right away. The median incubation period for COVID-19 is about five days, with meta-analyses putting the pooled estimate around 5.1 to 5.6 days.⁹¹⁰ Almost everyone who develops symptoms does so within about 11 to 12 days, though a small fraction can take longer. The Omicron variant tended to produce symptoms slightly faster than earlier strains, often within two to four days of exposure.

The typical pattern for a mild case starts with fatigue, a sore throat, and possibly a headache, followed within a day or two by cough, congestion, and sometimes fever. For most people, the worst symptoms peak around days three through five of illness and then gradually improve over the following week. Shortness of breath, when it occurs, tends to show up a bit later, often around days five through eight, which is one reason physicians advise monitoring symptoms closely during that window even if you felt like you were improving.

How Symptoms Differ by Variant

Each major SARS-CoV-2 variant has brought a somewhat different symptom profile. The mutations that gave these variants an advantage in spreading also changed which parts of the body they affected most.¹¹ Delta was associated with more severe lower-respiratory disease and higher hospitalization rates. Omicron, by contrast, tended to cause more upper-airway symptoms. Contact tracing data from England found that sore throat was nearly twice as strongly associated with Omicron as with Delta, and that cough, fever, muscle aches, and diarrhea were all slightly more common in Omicron infections after adjusting for age and vaccination status.¹²

The trade-off with Omicron was lower severity overall. Hospital admission was less common during the Omicron period compared to Delta, at roughly 1.9% versus 2.6%.³ That does not mean Omicron was harmless, but the symptom experience for the average person shifted toward something milder and more cold-like. As the virus continues to evolve, the symptom picture will keep shifting, making it harder to rely on any fixed checklist.

Telling COVID Apart from Flu, RSV, and a Common Cold

One of the most frustrating aspects of COVID-19 is how much its symptoms overlap with other respiratory infections. A community surveillance study comparing symptom profiles across influenza, RSV, rhinovirus, and multiple SARS-CoV-2 variants found that cough was common across all of them, reaching roughly 80% to 90% in most cases. The biggest distinguishing factor was fever: it showed up in about 74% of influenza cases but on average only about 17% of COVID-19 cases across variants, with Omicron subvariants producing fever in an even smaller proportion.¹³ That runs counter to what many people expect, since fever was a hallmark of earlier pandemic waves, and it underscores how much the symptom landscape has changed.

In hospitalized adults, RSV tends to produce more signs of lower respiratory infection and more markers of low oxygen and inflammation compared to both influenza and COVID-19.¹⁴ In children, RSV is more likely to cause nasal blockage, wheezing, and a severe sleep-disrupting cough compared to COVID-19.¹⁵ Allergic rhinitis can also mimic early COVID, though it tends to involve more sneezing and itchy eyes and less body ache or fatigue. The practical upshot: you cannot reliably distinguish these infections by symptoms alone. A rapid test is the only way to know for sure.

Symptoms in Children and Older Adults

COVID-19 does not look the same at every age. Children generally have milder acute illness than adults, but a small subset develop a serious post-infectious condition called multisystem inflammatory syndrome in children, or MIS-C. This typically appears two to six weeks after the initial infection and is marked by a high frequency of gastrointestinal symptoms, with about 71% of affected children experiencing gut problems like abdominal pain and diarrhea.¹⁶ The condition can also involve the heart, blood system, and skin, sometimes resembling Kawasaki disease.¹⁷ MIS-C is uncommon but serious, with about 68% of documented cases requiring intensive care in early studies.¹⁶ Parents should be alert to persistent fever, stomach pain, rash, or unusual lethargy in a child who had COVID or was exposed a few weeks earlier.

At the other end of the age spectrum, older adults, especially those who are frail, can present in ways that do not look like a typical respiratory infection at all. Delirium, meaning sudden confusion, disorientation, or altered awareness, showed up in about 28% of older COVID patients presenting to emergency departments in one study, making it the sixth most common presenting symptom. Among those with delirium, 37% had no typical COVID signs like fever or shortness of breath at all.¹⁸ Frailty made this far more likely: frail patients were about three times as likely to present with delirium compared to non-frail patients of similar age.¹⁹ If an elderly family member suddenly becomes confused or unusually drowsy, COVID should be on the list of possible causes even if they have no cough or fever.

Silent Hypoxemia and Emergency Warning Signs

Perhaps the most dangerous quirk of COVID-19 is its ability to cause dangerously low blood oxygen levels without making you feel short of breath. This phenomenon, called silent hypoxemia, puzzled physicians early in the pandemic because patients would arrive at the hospital with oxygen saturations that would normally leave someone gasping, yet they felt relatively comfortable.²⁰ In one emergency department study, 13% of COVID patients who arrived with oxygen levels below 90% had no sensation of breathlessness. Of those patients, 34% ended up intubated and 60% were admitted to the ICU.²¹

The mechanisms behind silent hypoxemia involve several factors. Tiny blood clots in the lung’s capillaries can throw off the balance between airflow and blood flow. The virus may also interfere with how hemoglobin carries oxygen, and shifts in blood chemistry can reduce the brain’s normal alarm response to low oxygen.²² This is one reason health authorities encouraged home pulse oximeter use during COVID surges. Consumer-grade pulse oximeters have been shown to be accurate enough for meaningful home monitoring.²³

Beyond silent hypoxemia, here are signs that should prompt immediate medical attention:

Persistent chest pain or pressure: especially if it does not go away with rest or position changes.
Confusion or inability to stay awake: new disorientation that is not explained by medication or fatigue alone.
Bluish lips, face, or fingertips: a visible sign that oxygen is not circulating properly.
Worsening shortness of breath: particularly if it comes on suddenly or prevents you from completing a sentence.
Oxygen reading below 94%: if you have a pulse oximeter at home, a reading that stays below this level at rest is a reason to call your doctor or go to the emergency room.

At-Home Care for Mild Cases

Most people with COVID-19 can recover at home. Updated CDC guidelines affirm that over-the-counter medications like acetaminophen and ibuprofen are appropriate for managing symptoms such as fever, headache, and body aches.²⁴ A review of the evidence concluded that the same OTC treatments used for common cold and flu symptoms are safe and effective for the corresponding symptoms of COVID-19.²⁵

Providers treating outpatient COVID have reported high perceived effectiveness from a handful of readily available treatments: acetaminophen for fever, NSAIDs for aches and headaches, non-sedating antihistamines for runny nose and sneezing, and nasal steroid sprays for congestion.²⁶ Staying hydrated matters more than most people realize, especially with fever and diarrhea pulling fluid from the body. Rest, while obvious advice, is worth emphasizing: pushing through mild COVID-19 to maintain normal activity levels can prolong the illness and may increase the risk of lingering symptoms.

Separate from symptom management, antiviral treatments like nirmatrelvir-ritonavir (Paxlovid) are available for people at higher risk of severe disease. These work best when started within the first five days of symptoms, so getting tested promptly matters if you are in a higher-risk group due to age, immune suppression, or chronic health conditions.

When to Test and What Timing Means for Accuracy

Rapid antigen tests are most accurate when the virus is replicating quickly, which tends to happen in the first week of symptoms. Research confirms that antigen test sensitivity is highest during the first seven days after symptom onset and drops off noticeably after that point.²⁷ In one clinical study, antigen test positivity was around 54% during the first week of symptoms and exceeded PCR positivity on symptom days four through eight, but then declined faster than PCR positivity thereafter.²⁸

If you test negative on a rapid test during the first day or two of symptoms, that does not rule out COVID. Viral load may simply not be high enough yet. Repeating the test 24 to 48 hours later catches many cases that were missed on the first try. PCR tests remain more sensitive overall and are the better option if you need a definitive answer, especially later in the illness when viral shedding has decreased and rapid tests become unreliable.

How Vaccination Changes the Symptom Picture

Vaccinated people can still catch COVID-19, but breakthrough infections tend to look different from infections in unvaccinated individuals. The most consistent finding across studies is reduced severity. Unvaccinated patients have been significantly more likely to develop severe or critical disease, need intensive care, and die compared to vaccinated patients, even after adjusting for age and other health conditions.²⁹ Among vaccinated patients who were hospitalized, the length of stay was shorter by a median of two to three days compared to unvaccinated patients. Vaccinated individuals also showed lower rates of lung involvement: in one study, about 22% of the vaccinated group had pulmonary symptoms versus 47% of the unvaccinated group.³⁰

In everyday terms, a breakthrough infection in a vaccinated person is more likely to feel like a cold or mild flu, with sore throat, runny nose, and headache being the dominant complaints. The deeper lung involvement, prolonged fevers, and dangerous oxygen drops that characterized severe COVID in unvaccinated patients are far less common after vaccination, though they are not impossible, especially in immunocompromised individuals or those who are many months past their last dose.

Long COVID and Lingering Symptoms

For some people, symptoms do not wrap up neatly after a week or two. An estimated 6% of people with symptomatic COVID-19 who were not hospitalized experienced at least one cluster of long COVID symptoms, a proportion that climbed sharply with disease severity: roughly 28% of those admitted to a regular hospital ward and about 43% of ICU patients developed persistent symptoms.³¹ The three symptom clusters tracked in that analysis were persistent fatigue, cognitive problems, and ongoing respiratory symptoms, and women were more likely to be affected than men.

Brain fog has become one of the most talked-about long COVID symptoms. A systematic review found a pooled prevalence of about 30% for brain fog and 25% for cognitive impairment among people with long COVID.³² People describe it as difficulty concentrating, forgetting words mid-sentence, or feeling mentally sluggish in ways they never experienced before getting sick. The severity ranges from mildly annoying to functionally disabling, and the duration is unpredictable. Some people improve steadily over months; others report symptoms lasting well over a year.

Stroke and Neurological Complications

Beyond brain fog, COVID-19 has been linked to more acute neurological events. Early studies found that about 5% to 6% of patients with severe infections developed cerebrovascular disease, with a median age in the early 70s. More broadly, neurological involvement of some kind was reported in roughly 37% of hospitalized patients, and critically ill ICU patients showed thrombotic complications at a rate of about 31%.³³ These complications are tied to the virus’s tendency to trigger inflammation and clotting throughout the blood vessels, including those supplying the brain. Children can also be affected neurologically through MIS-C, which has been associated with neurological symptoms including headache, confusion, and in rarer cases, seizures or encephalopathy.³⁴

The immune response itself can compound the damage. COVID-19 triggers a two-phase immune reaction: the body’s initial defense tries to contain the virus in infected cells, but if that fails, a runaway inflammatory cascade can develop as the virus spreads.³⁵ In severe cases, inflammatory markers like IL-1β start high and stay elevated for more than two weeks, whereas in mild cases they tend to peak in the second week and then decline.³⁶ That sustained inflammation is what drives many of the organ-threatening complications, from lung scarring to clot formation to neurological damage. It is also why some physicians track inflammatory blood markers as a way to gauge whether a patient’s illness is heading in a dangerous direction.